The aberrant expression patterns and the pivotal role of CLDN3 in maintaining cellular polarity and ion flux underscore its significance in cancer pathology and as a candidate for targeted CAR-T cell therapy, aimed at improving treatment specificity and efficacy against ovarian cancer. The gene discussed is CLDN3; the disease is ovarian cancer.